Filing Details
- Accession Number:
- 0000950170-25-078552
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-05-28 21:52:55
- Reporting Period:
- 2025-05-27
- Filing Date:
- 2025-05-28
- Accepted Time:
- 2025-05-28 21:52:55
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1579428 | Axsome Therapeutics Inc. | AXSM | Pharmaceutical Preparations (2834) | 454241907 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1805812 | L. Mark Jacobson | C/O Axsome Therapeutics, Inc. One World Trade Center, 29Th Floor New York NY 10007 | Chief Operating Officer | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2025-05-27 | 20,673 | $6.47 | 26,456 | No | 4 | M | Direct | |
Common Stock | Disposition | 2025-05-27 | 20,673 | $104.66 | 5,783 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2025-05-28 | 20,000 | $6.47 | 25,783 | No | 4 | M | Direct | |
Common Stock | Disposition | 2025-05-28 | 20,000 | $103.45 | 5,783 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2025-05-27 | 20,673 | $0.00 | 20,673 | $6.47 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2025-05-28 | 20,000 | $0.00 | 20,000 | $6.47 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2016-09-15 | 2025-09-15 | No | 4 | M | Direct |
0 | 2016-09-15 | 2025-09-15 | No | 4 | M | Direct |
Footnotes
- Represents an exercise of stock options prior to the 10-year expiration date of such options, which would occur within 12 months.
- Such transaction was pursuant to a pre-approved 10b5-1 plan.
- Represents the subsequent sale of the underlying shares of the aforementioned exercise of stock options.
- Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $103.96 and $106.44.
- Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $102.67 and $104.22.